859 related articles for article (PubMed ID: 15555699)
1. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
[TBL] [Abstract][Full Text] [Related]
2. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
Gum AM; King-Kallimanis B; Kohn R
Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
[TBL] [Abstract][Full Text] [Related]
4. Considering comorbidity in social phobia.
Chartier MJ; Walker JR; Stein MB
Soc Psychiatry Psychiatr Epidemiol; 2003 Dec; 38(12):728-34. PubMed ID: 14689178
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study.
de Graaf R; Bijl RV; Smit F; Vollebergh WA; Spijker J
Am J Psychiatry; 2002 Apr; 159(4):620-9. PubMed ID: 11925301
[TBL] [Abstract][Full Text] [Related]
6. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions.
Sareen J; Jacobi F; Cox BJ; Belik SL; Clara I; Stein MB
Arch Intern Med; 2006 Oct; 166(19):2109-16. PubMed ID: 17060541
[TBL] [Abstract][Full Text] [Related]
7. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
Bolton JM; Robinson J; Sareen J
J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
[TBL] [Abstract][Full Text] [Related]
8. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
Teesson M; Slade T; Mills K
Aust N Z J Psychiatry; 2009 Jul; 43(7):606-14. PubMed ID: 19530017
[TBL] [Abstract][Full Text] [Related]
10. Lifetime prevalence, correlates, and persistence of oppositional defiant disorder: results from the National Comorbidity Survey Replication.
Nock MK; Kazdin AE; Hiripi E; Kessler RC
J Child Psychol Psychiatry; 2007 Jul; 48(7):703-13. PubMed ID: 17593151
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Stinson FS; Grant BF; Dawson DA; Ruan WJ; Huang B; Saha T
Drug Alcohol Depend; 2005 Oct; 80(1):105-16. PubMed ID: 16157233
[TBL] [Abstract][Full Text] [Related]
12. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
[TBL] [Abstract][Full Text] [Related]
13. Stress burden and the lifetime incidence of psychiatric disorder in young adults: racial and ethnic contrasts.
Turner RJ; Lloyd DA
Arch Gen Psychiatry; 2004 May; 61(5):481-8. PubMed ID: 15123493
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity and impact of chronic spinal pain in Nigeria.
Gureje O; Akinpelu AO; Uwakwe R; Udofia O; Wakil A
Spine (Phila Pa 1976); 2007 Aug; 32(17):E495-500. PubMed ID: 17762283
[TBL] [Abstract][Full Text] [Related]
15. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
Simmons LA; Havens JR
J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing.
McEvoy PM; Grove R; Slade T
Aust N Z J Psychiatry; 2011 Nov; 45(11):957-67. PubMed ID: 22044173
[TBL] [Abstract][Full Text] [Related]
17. The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey.
Sareen J; Cox BJ; Clara I; Asmundson GJ
Depress Anxiety; 2005; 21(4):193-202. PubMed ID: 16075453
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of trauma-related disorders in the French WHO study: Santé mentale en population générale (SMPG)].
Vaiva G; Jehel L; Cottencin O; Ducrocq F; Duchet C; Omnes C; Genest P; Rouillon F; Roelandt JL
Encephale; 2008 Dec; 34(6):577-83. PubMed ID: 19081454
[TBL] [Abstract][Full Text] [Related]
19. Young adults' relationship transitions and the incidence of mental disorders: a three-wave longitudinal study.
Overbeek G; Vollebergh W; Engels RC; Meeus W
Soc Psychiatry Psychiatr Epidemiol; 2003 Dec; 38(12):669-76. PubMed ID: 14689170
[TBL] [Abstract][Full Text] [Related]
20. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
